Eben Tessari stock trades
Chief Strategy Officer of Kiniksa Pharmaceuticals International
4 open-market trades reported in the last 12 months: 4 sales for $1.5M. Every sale was under a trading plan set up in advance. The newest was filed Dec 17, 2025.
Where Eben Tessari files
Each title as their newest Form 4 there gives it, and the open-market trades there in the last 12 months. Open any stock for its score. Pro members see every stock ranked.
| Company | Trades | Quality Score |
|---|---|---|
| 4 |
Eben Tessari's trades, as filed
Open-market buys and sales, newest first, each with its Form 4 on the SEC's site. A Plan tag marks a sale under a trading plan set up in advance.
| Stock | Trade | Traded |
|---|---|---|
| SellPlan$501K | Dec 15, 2025SEC filing | |
| SellPlan$9K | Nov 26, 2025SEC filing | |
| SellPlan$514K | Nov 17, 2025SEC filing |
1 more trade on record, and 9 other filings (option exercises and tax withholdings). Pro members see every trade, the shares Eben Tessari held after each, and every filing.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.